VOYA Investment Management
ICPT

VOYA Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

VOYA Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-16,774
Closed -$311K – 2945
2023
Q3 		$311K Buy
+16,774
New +$190K ﹤0.01% 2290
2023
Q1 		– Sell
-10,021
Closed -$124K – 2941
2022
Q4 		$124K Hold
10,021
– – ﹤0.01% 2708
2022
Q3 		$140K Hold
10,021
– – ﹤0.01% 2704
2022
Q2 		$138K Sell
10,021
-1,043
-9% -$16.7K ﹤0.01% 2539
2022
Q1 		$180K Sell
11,064
-9,466
-46% -$148K ﹤0.01% 2393
2021
Q4 		$334K Buy
20,530
+1,464
+8% +$24.7K ﹤0.01% 2242
2021
Q3 		$283K Buy
19,066
+260
+1% +$4.16K ﹤0.01% 2378
2021
Q2 		$376K Buy
18,806
+884
+5% +$17.5K ﹤0.01% 2260
2021
Q1 		$414K Buy
17,922
+3,178
+22% +$88.6K ﹤0.01% 2135
2020
Q4 		$364K Buy
14,744
+3,469
+31% +$115K ﹤0.01% 2100
2020
Q3 		$467K Sell
11,275
-59,319
-84% -$2.73M ﹤0.01% 1712
2020
Q2 		$3.38M Sell
70,594
-15,869
-18% -$1.23M 0.01% 873
2020
Q1 		$5.44M Sell
86,463
-8,456
-9% -$760K 0.01% 679
2019
Q4 		$11.8M Sell
94,919
-42,957
-31% -$3.85M 0.02% 561
2019
Q3 		$9.15M Buy
137,876
+7,269
+6% +$488K 0.02% 622
2019
Q2 		$10.4M Buy
130,607
+4,607
+4% +$412K 0.02% 599
2019
Q1 		$14.1M Buy
126,000
+22,304
+22% +$2.44M 0.03% 467
2018
Q4 		$10.5M Buy
103,696
+1,503
+1% +$156K 0.03% 526
2018
Q3 		$12.9M Buy
102,193
+93,732
+1,108% +$9.92M 0.03% 540
2018
Q2 		$710K Buy
8,461
+1,978
+31% +$145K ﹤0.01% 1587
2018
Q1 		$399K Sell
6,483
-9,730
-60% -$586K ﹤0.01% 1940
2017
Q4 		$947K Buy
16,213
+7,963
+97% +$502K ﹤0.01% 1451
2017
Q3 		$479K Buy
8,250
+1,256
+18% +$135K ﹤0.01% 1900
2017
Q2 		$847K Buy
6,994
+313
+5% +$36.3K ﹤0.01% 1507
2017
Q1 		$756K Sell
6,681
-509
-7% -$59.4K ﹤0.01% 1491
2016
Q4 		$781K Sell
7,190
-246
-3% -$29.3K ﹤0.01% 1472
2016
Q3 		$1.22K Buy
7,436
+205
+3% +$32.3K ﹤0.01% 1217
2016
Q2 		$1.03M Buy
7,231
+130
+2% +$19K ﹤0.01% 1256
2016
Q1 		$912K Sell
7,101
-58
-0.8% -$6.85K ﹤0.01% 1324
2015
Q4 		$1.07M Sell
7,159
-190
-3% -$32.2K ﹤0.01% 1252
2015
Q3 		$1.22M Sell
7,349
-69
-0.9% -$15.2K ﹤0.01% 1198
2015
Q2 		$1.79M Buy
7,418
+1,159
+19% +$309K ﹤0.01% 1121
2015
Q1 		$1.76M Buy
6,259
+131
+2% +$28.4K ﹤0.01% 1143
2014
Q4 		$956K Sell
6,128
-167
-3% -$30.8K ﹤0.01% 1473
2014
Q3 		$1.49M Sell
6,295
-50
-0.8% -$12.7K ﹤0.01% 1204
2014
Q2 		$1.5M Buy
6,345
+2,330
+58% +$614K ﹤0.01% 1250
2014
Q1 		$1.32M Hold
4,015
– – ﹤0.01% 1305
2013
Q4 		$274K Buy
+4,015
New +$232K ﹤0.01% 2360

VOYA Investment Management's ICPT Position: Q4 2023 in Review

VOYA Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 16,774 shares — an estimated $311K sold.

VOYA Investment Management first reported a position in ICPT in Q4 2013 and held it in 38 quarters. The position peaked at $14.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • VOYA Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • VOYA Investment Management sold 16,774 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $311K.
  • VOYA Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 38 quarters.
  • VOYA Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $14.1M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on VOYA Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.